EMA: Q&As on the Topic of "Parallel Distribution" updated

Recommendation
Tuesday, 23 September 2025 13.00 - 17.00 h
Again, the "Frequently asked questions about parallel distribution" were revised and published on the EMA website. The information provided by the EMA on parallel distribution of centrally authorised medicinal products is set out in the Q&A in six paragraphs:
- General
- Initial notification
- Parallel distribution notification check
- Post - Parallel distribution notice guidance
- Safety updates/bulk changes/annual update
- Fees
In the latest version, the following question has been added to the first section "General":
- 07. What to do when my organisation details have changed?
In the fifth paragraph "Safety updates/bulk changes/annual update", questions 4 and 5 and their answers have been updated:
- 04. How to submit a bulk change?
- 05. What is an annual update?
The four other sections remain unchanged.
The updates and the complete list of answers to the "Frequently asked questions about parallel distribution" can be found on the EMA website.
Related GMP News
10.09.2025Centralised Procedures: Updated Q&As
03.09.2025EMA updates IRIS Documents
06.08.2025WHO: TRS 1060 regulatory Guidelines published
30.07.2025Swissmedic/EMA: M4Q(R2) Guideline published for Comment
23.07.2025FDA: Complete Response Letters published
02.07.2025ICH M4Q Guideline Updated